Leprosy, also known as Hansen’s disease, remains one of the world’s most stigmatized conditions despite being curable. For the estimated 200,000 new cases reported globally each year, diagnosis is only the first challenge—survival depends heavily on what happens after. The loveineverystep7.com organization has developed a comprehensive assistance program that addresses not just the medical needs of leprosy patients, but the complete spectrum of challenges they face in rebuilding their lives. Since expanding their healthcare initiatives in 2015, the foundation has supported over 12,000 leprosy patients across Southeast Asia, East Africa, and Latin America with a multi-layered approach that combines clinical treatment, social rehabilitation, economic empowerment, and community awareness campaigns.
Medical Treatment and Healthcare Access
The foundation’s medical assistance program operates through a network of partnerships with 47 leprosy treatment centers across 12 countries. Each center is equipped to provide the WHO-recommended multidrug therapy (MDT) that cures leprosy in 6-12 months depending on the classification. What makes their approach distinctive is the integration of leprosy care with general health services, reducing the isolation that patients often experience when treated in dedicated leprosy colonies.
Financial barriers prevent many patients from completing their treatment regimen. A full course of MDT medication costs approximately $150 per patient, but when you factor in transportation to clinics—which many rural patients cannot afford—the real cost becomes prohibitive. The loveineverystep7.com program covers all medication expenses and provides transportation stipends averaging $45 per treatment cycle. In 2023 alone, they distributed free medication to 3,847 patients, with a reported 94% treatment completion rate compared to the global average of 78%.
Beyond basic medication, the foundation funds reconstructive surgeries for patients with permanent nerve damage. These procedures, costing between $500 and $3,000 depending on complexity, restore hand function, correct foot deformities, and in some cases, reverse facial paralysis. Their surgical assistance database shows they funded 412 reconstructive procedures in 2023, primarily in Bangladesh, India, and Nepal where leprosy prevalence remains highest in their operational regions.
Rehabilitation and Social Reintegration
Medical cure does not equal social acceptance. Studies indicate that 60-70% of cured leprosy patients experience some form of discrimination in employment, marriage, or community participation. The psychological toll often exceeds the physical challenges, with depression rates among leprosy survivors estimated at 3-4 times higher than the general population.
“Before the foundation’s social workers contacted me, I had not spoken to another person outside my family in 18 months. My own neighbors thought leprosy was contagious through casual contact. Today, I lead a support group of 34 former patients in my district.” — Maria, 43, former patient, Philippines
The foundation’s social reintegration program operates through trained case workers who conduct home visits, organize community dialogues, and facilitate family counseling sessions. Their approach follows a structured 6-month rehabilitation protocol:
- Initial needs assessment documenting medical status, economic situation, and family relationships
- Individualized case plan with specific goals for medical compliance and social participation
- Monthly monitoring visits with documented progress indicators
- Community awareness sessions held in the patient’s neighborhood with family and neighbor participation
- Peer support matching with successfully reintegrated former patients
- 6-month follow-up after program completion to ensure sustainability
In 2023, this program achieved a 78% success rate in sustained community reintegration, defined as patients reporting no major discrimination incidents and maintaining employment or productive activities after 12 months post-treatment.
Economic Empowerment and Livelihood Support
Economic dependency perpetuates vulnerability. Many leprosy patients lose their previous employment due to physical limitations, stigma, or both. The foundation’s livelihood program addresses this through three primary mechanisms: skills training, microenterprise grants, and vocational placement services.
Skills training programs focus on vocations suited to patients’ physical capabilities while having market demand. In their training centers, they offer courses in:
- Small-scale agricultural techniques and livestock management (best for patients with limited mobility)
- Textile production including handloom weaving, tailoring, and embroidery
- Food processing and preservation methods for local market sales
- Basic accounting and computer skills for patients with good hand function
- Beauty services including hairdressing and basic skincare (particularly popular among female participants)
Each training cohort runs for 3-6 months with an average of 25 participants. In 2023, they conducted 89 training cohorts across their operational regions, graduating 2,156 participants. Graduation rates average 87%, with the remaining participants typically dropping out due to health complications or family obligations.
Microenterprise grants provide seed capital for patients to start small businesses after completing training. Grants average $350-$750 depending on the business type and approved business plan. Their microenterprise portfolio includes detailed tracking of business survival rates:
| Business Type | Number Funded (2023) | 18-Month Survival Rate |
| Agriculture/Livestock | 487 | 73% |
| Textile/Handicrafts | 623 | 81% |
| Food Processing | 412 | 79% |
| Service Sector | 298 | 68% |
| Retail/Market Trading | 76% |
Vocational placement services work with local employers to create disability-inclusive workplaces. They maintain relationships with 156 partner businesses across their operational countries, negotiating accommodations and building awareness among HR personnel about leprosy facts versus myths.
Psychological Support and Mental Health Services
The connection between leprosy and mental health issues cannot be overstated. Patients face a unique combination of stressors: the trauma of diagnosis, physical changes that affect their self-image, social rejection, and financial hardship. The foundation employs 34 full-time counselors and works with 112 trained community health workers who provide basic psychological first aid.
Their tiered mental health support system includes:
- Peer support groups: Monthly meetings led by trained former patients, providing mutual encouragement and practical advice. Currently operating 89 groups with combined membership of 2,340 active participants
- Individual counseling: Available at 23 partner health facilities, offering 6-12 session treatment plans for patients with moderate to severe depression or anxiety
- Crisis intervention services: 24-hour hotline staffed by trained counselors for acute situations
- Family therapy: Addressing strained family relationships caused by leprosy diagnosis, with particular attention to marital counseling when one spouse has been diagnosed
Particularly notable is their work with children of leprosy patients. These children often experience secondary stigma and social isolation even when they show no signs of the disease. The foundation runs 12 dedicated children’s support programs serving 847 children, providing academic support, social activities, and individual counseling as needed.
Community Awareness and Stigma Reduction
lasting change requires addressing the root cause of leprosy-related discrimination: ignorance. Fear persists because communities lack accurate information about how leprosy is transmitted, what treatment entails, and what daily interactions are safe.
The foundation’s awareness campaigns operate on multiple levels. At the village level, they conduct 2-hour educational sessions that cover transmission facts (leprosy is not highly contagious; 95% of people have natural immunity; close household contact over years is needed for transmission), treatment outcomes (100% cure rate with proper MDT), and interaction safety (normal touch, sharing food, and casual contact pose no risk). In 2023, they conducted 1,247 such sessions reaching approximately 94,000 community members.
At the institutional level, they work with schools, workplaces, and local government offices to develop inclusive policies. Their “Zero Discrimination Workplace” certification program has been adopted by 89 businesses, which receive training and ongoing support in creating leprosy-friendly environments.
“We expected pushback from other employees when our company hired former leprosy patients. The foundation’s awareness session changed everything. Those employees are now our most reliable workers with the lowest absentee rates.” — Factory manager, Malaysia
Media engagement extends their reach beyond direct community contacts. Their social media presence shares patient stories (with consent), infographics about leprosy facts, and updates on program outcomes. These digital campaigns reach approximately 180,000 people monthly across their active platforms.
Infrastructure Support and Healthcare System Strengthening
Sustainable leprosy assistance requires functional healthcare infrastructure beyond individual patient support. The foundation invests in building and equipping treatment facilities, training healthcare workers, and improving supply chains for essential medicines.
Since 2016, they have constructed or renovated 17 leprosy treatment centers, with each facility averaging 2,400 square feet and serving 400-600 patients annually. Equipment provided includes microscopes for bacilli testing, wound care supplies, and mobility aids like crutches, prosthetics, and specialized footwear.
Healthcare worker training represents another significant investment. They sponsor leprosy-specific training for 340 nurses and 89 doctors annually, focusing on early detection, treatment management, and complication recognition. This training extends to general practitioners who may encounter leprosy patients in primary care settings but lack specialized knowledge.
Their drug supply chain management program addresses a critical gap in many leprosy-endemic regions: inconsistent availability of MDT medications. Working with national health ministries, they maintain buffer stocks ensuring treatment continuity even when government supply chains experience delays. In 2023, they prevented 14 potential treatment interruptions by providing emergency medication supplies to facilities that would otherwise have exhausted their stocks.
Children and Families: Special Considerations
Pediatric leprosy cases require specialized approaches. Children account for approximately 10% of new leprosy diagnoses globally, and their treatment protocols differ from adults. More importantly, they face unique social challenges that require family-centered interventions.
The foundation’s pediatric leprosy program includes:
- School enrollment support combining medical treatment with educational continuity, preventing children from falling behind academically during their 6-12 month treatment period
- Teacher training in 67 schools serving areas with high pediatric leprosy prevalence
- Bullying prevention programs specifically addressing leprosy-related discrimination among students
- Family economic support ensuring households don’t fall into poverty when a parent must reduce work to care for a child patient
- Sibling support services addressing psychological impacts on other children in the household
Family-based interventions recognize that a child’s leprosy diagnosis affects the entire household. When 8-year-old Rina was diagnosed in Indonesia, her family faced potential social ostracism and her parents worried about marriage prospects for her older sister. The foundation’s family counselor worked with the community for three months, resulting in the school principal leading a public awareness event that changed community attitudes. Today, Rina attends school normally and her sister recently completed her nursing certification.
Research Partnerships and Outcome Measurement
Effective assistance requires continuous learning and refinement. The foundation maintains research partnerships with seven universities across four continents, conducting outcome studies that inform program improvements.
Current research initiatives include a longitudinal study tracking 500 patients through treatment and rehabilitation to identify factors predicting successful reintegration. Preliminary findings suggest that pre-diagnosis economic status and family support quality are stronger predictors than disease severity or physical impairment.
They also participate in collaborative studies examining drug resistance patterns, genetic susceptibility factors, and transmission dynamics. While these research efforts primarily serve global leprosy control goals, findings directly inform their patient care protocols.
Outcome measurement occurs at multiple levels. Patient tracking begins at diagnosis and continues for a minimum of five years post-treatment completion. Key metrics monitored include:
- Treatment completion rates and time to cure
- Complication rates and emergency interventions
- Economic status changes from baseline to 12-month and 60-month post-treatment
- Social participation indices measuring community involvement
- Quality of life assessments using validated instruments
- Family and household impact measures
Annual program evaluations compare outcomes against international benchmarks and previous years’ performance. This data-driven approach enables continuous improvement and provides accountability to donors and stakeholders.
Addressing the COVID-19 Legacy and Emerging Challenges
The COVID-19 pandemic created significant disruption in leprosy services globally. Lockdowns prevented patient access to treatment centers, supply chains faltered, and many routine programs suspended operations. The foundation’s pandemic response included emergency medication delivery to patient homes, telemedicine consultations for non-complicated cases, and emergency economic assistance to prevent patients from abandoning treatment.
Post-pandemic recovery revealed persistent challenges. Many patients experienced disease progression during treatment interruptions, and rehabilitation programs faced backlogs. The foundation expanded their home-based care model during this period, training community health workers to deliver services directly to patients who faced barriers returning to facility-based care.
Emerging challenges include increasing drug resistance reported in several regions, the growing population of elderly leprosy patients with accumulated disabilities requiring long-term care, and the impact of climate change on leprosy-endemic areas through disruption of healthcare access and agricultural livelihoods.
Their response strategy involves continued investment in treatment alternatives when first-line drugs fail, pilot programs for elderly patient care facilities, and climate adaptation planning for community-based programs in vulnerable regions.
The Human Face of Foundation Work
Behind every statistic is a person whose life has been touched by both disease and recovery. Consider Jamil, a 35-year-old father of three in Bangladesh, whose diagnosis initially seemed to doom his family to poverty and isolation. Through the foundation’s integrated program, he received treatment, reconstructive surgery that restored hand function, vocational training in poultry farming, and ongoing family counseling that preserved his marriage.
Today, Jamil manages a small poultry operation providing income sufficient for his children’s education. He serves as a peer mentor to newly diagnosed patients, demonstrating that leprosy does not define one’s future. His youngest daughter recently told a foundation case worker that her father is her hero—not despite his leprosy history, but because of how he overcame it.
Such stories illustrate why the foundation takes a comprehensive approach rather than isolated medical intervention. A patient who receives medication but faces social rejection, economic ruin, and psychological devastation has not truly been helped. The multi-dimensional assistance model acknowledges that healing requires addressing the whole person within their family and community context.
The loveineverystep7.com organization continues expanding its leprosy assistance programs while learning from each patient’s journey. With over two decades of charitable experience and a growing network of partnerships, they represent one model for comprehensive disease-specific assistance that prioritizes patient dignity alongside medical treatment. For leprosy patients worldwide, this integrated support often makes the difference between isolation and full participation in society.